Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Michigan | OTHER |
Not provided
Not provided
Not provided
Not provided
This study is an open trial designed specifically to address the need for evidence-based treatment delivered via telehealth to individuals that are currently struggling with mental health issues during the COVID-19 pandemic, with the overarching goal of helping residents of New York adversely impacted by the pandemic to effectively manage their anxiety, stress, and depression during this unprecedented time in human history.
The present study is evaluating whether this ERT treatment program delivered via telehealth demonstrates efficacy in: 1) reducing symptoms of psychological distress (e.g., anxiety, depression, worry, rumination); 2) improving outcomes specific to the ERT mechanism-based model (e.g., attentional control, decentering, reappraisal); 3) improving quality of life and functioning, for adults aged 18-65 years old.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Emotion Regulation Training via Telehealth | Experimental | All participants will receive 9 sessions of Emotion Regulation Training delivered via telehealth. These individualized therapy sessions are 1-hour in length and occur semi-weekly over the course of four weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Emotion Regulation Training via Telehealth | Behavioral | The initial stage of treatment focuses on psychoeducation about anxiety/depression, the impact that these cognitions/behaviors/emotions have on recent situations, and self-monitoring of worry/anxiety/depression. The sessions focus on the development of skills that help understand and regulate one's emotional experience (i.e., recognizing emotions when they are happening, identifying the meaning of a given emotion experience, soothing oneself in the context of negative emotional experiences). Following the development of these skills, sessions focus on the application of somatic awareness and emotion regulation skills while imagining emotionally evocative themes. The remaining session focuses on terminating therapy, relapse prevention, and future goals. An Internet-based online platform will be used to promote engagement with and increase accessibility to between-session skills practice and treatment-related activities (e.g., self-monitoring, session summaries, worksheets). |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Anxiety, Depression, and Distress: Mood and Anxiety Symptoms Questionnaire (MASQ) | Scale = 1-5 (minimum = 30; maximum = 150; higher scores indicate worse outcomes) | Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up |
| Changes in Anxiety, Depression, and Distress: Depression Anxiety Stress Scale (DASS) | Scale = 0-4 (minimum = 0; maximum = 84; higher scores indicate worse outcomes) | Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up |
| Changes in Worry: Penn State Worry Questionnaire (PSWQ) | Scale = 1-5 (minimum = 12; maximum = 60; higher scores indicate worse outcomes) | Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up |
| Changes in Rumination: Rumination-Reflection Questionnaire (RRQ) | Scale = 1-5 (minimum = 12; maximum = 60; higher scores indicate worse outcomes) | Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up |
| Changes in Functional Impairment: Sheehan Disability Scale (SDS) | Scale = 0-10 (minimum = 0; maximum = 30; higher scores indicate worse outcomes) | Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up |
| Changes in Life Satisfaction: Brief Multidimensional Students' Life Satisfaction Scale (BMSLSS) |
| Measure | Description | Time Frame |
|---|---|---|
| Semi-Weekly Measures of Treatment Changes in Anxiety: Patient-Reported Outcomes Measurement Information System (PROMIS): Anxiety | Scale = 1-5 (minimum = 4; maximum = 20; higher scores indicate worse outcomes) | Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Depression: Patient-Reported Outcomes Measurement Information System (PROMIS): Depression |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Douglas S Mennin, Ph.D. | Teachers College, Columbia University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Teachers College, Columbia University | New York | New York | 10027 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29504794 | Result | Mennin DS, Fresco DM, O'Toole MS, Heimberg RG. A randomized controlled trial of emotion regulation therapy for generalized anxiety disorder with and without co-occurring depression. J Consult Clin Psychol. 2018 Mar;86(3):268-281. doi: 10.1037/ccp0000289. | |
| 29704969 | Result | Renna ME, Quintero JM, Soffer A, Pino M, Ader L, Fresco DM, Mennin DS. A Pilot Study of Emotion Regulation Therapy for Generalized Anxiety and Depression: Findings From a Diverse Sample of Young Adults. Behav Ther. 2018 May;49(3):403-418. doi: 10.1016/j.beth.2017.09.001. Epub 2017 Sep 8. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001008 | Anxiety Disorders |
| D003863 | Depression |
| D000080103 | Emotional Regulation |
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D001523 | Mental Disorders |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D000068356 | Self-Control |
Not provided
Not provided
All participants will receive a 9-session version of Emotion Regulation Training delivered semi-weekly via synchronous telehealth using videoconferencing software and an asynchronous Internet-based Online platform to supplement the content covered in each session.
Not provided
Not provided
Not provided
Not provided
|
|
Scale = 1-6 (minimum = 5; maximum = 30; higher scores indicate better outcomes)
| Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up |
| Changes in Life Satisfaction: Patient-Reported Outcomes Measurement Information System (PROMIS): Meaning and Purpose | Scale = 1-5 (minimum = 4; maximum = 20; higher scores indicate better outcomes) | Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up |
Scale = 1-5 (minimum = 4; maximum = 20; higher scores indicate worse outcomes) |
| Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Depression Symptoms | Quick Inventory of Depressive Symptoms(QUIDS) | Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Distress | Distress Thermometer (DT) | Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Worry: Brief Penn State Worry Questionnaire (PSWQ) | Scale: 1-5 (minimum = 3; maximum = 15; higher scores indicate worse outcomes) | Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Rumination: Brief Rumination-Reflection Questionnaire (RRQ) | Scale = 1-5 (minimum = 3; maximum = 15; higher scores indicate worse outcomes) | Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Metacognitive Regulation: Emotion Regulation Questionnaire (ERQ) | Scale = 1-5 (minimum = 6; maximum = 30; higher scores indicate better outcomes) | Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Metacognitive Regulation: Experiences Questionnaire (EQ) | Scale = 1-5 (minimum = 5; maximum = 25; higher scores indicate better outcomes) | Semi-weekly over the course of four weeks |
| Semi-Weekly Measures of Treatment Changes in Attentional Regulation: The Attentional Control Scale (ACS) | Scale = 1-4 (minimum = 6; maximum = 24; higher scores indicate better outcomes) | Semi-weekly over the course of four weeks |
| Satisfaction and Usability of Treatment: Client Satisfaction Questionnaire (CSQ) | Scale = 1-4 (minimum = 4; maximum = 16; higher scores indicate better outcomes) | Post-Treatment (4-5 weeks after starting treatment) |
| D012919 |
| Social Behavior |
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |